| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $103.4M | +67.5% | +50.7% |
| Cost of Revenue | $86.6M | +7.2% | +53.0% |
| Gross Profit | $16.8M | +188.2% | +39.8% |
| R&D Expense | $7.7M | +347.3% | +306.4% |
| SG&A Expense | $50.3M | -7.7% | +187.0% |
| Operating Income | -$41.9M | +54.5% | -234.5% |
| Pre-tax Income | -$34.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $52.3M | -31.7% | +88.1% |
| Accounts Receivable | $32.0M | -13.1% | +41.2% |
| Inventory | $53.5M | -9.1% | +2503.0% |
| Current Assets | $210.6M | -13.9% | +66.5% |
| Total Assets | $1.45B | -4.1% | +398.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$153.1M | — | — |
| Capital Expenditures | $11.3M | — | — |
| Investing Cash Flow | -$169.2M | — | — |
| Financing Cash Flow | $326.9M | — | — |
| Free Cash Flow | -$164.4M | — | — |
| +73.5% |
| -60.0% |
| Income Tax | $6.9M | +121.0% | +1553.8% |
| Net Income | -$41.2M | +57.6% | -96.3% |
| EPS (Basic) | -$0.29 | +79.4% | +21.6% |
| EPS (Diluted) | -$0.29 | +79.4% | +21.6% |
| $149.6M |
| -10.7% |
| +14.2% |
| Long-term Debt | $191.0M | +0.1% | +54.9% |
| Total Liabilities | $413.3M | -7.9% | +48.9% |
| Stockholders' Equity | $928.0M | +2.3% | +1062.5% |